High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes

Background. Impairments of endocrine system may be associated with exposure to perfluorinated compounds that are able to bind nuclear receptors, including the peroxisome proliferator-activating receptors. Aim of this study was to assess perfluorooctane sulfonate and perfluorooctanoic acid concentrat...

Full description

Saved in:
Bibliographic Details
Main Authors: Barbara Predieri, Lorenzo Iughetti, Cristiana Guerranti, Patrizia Bruzzi, Guido Perra, Silvano E. Focardi
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2015/234358
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566900167540736
author Barbara Predieri
Lorenzo Iughetti
Cristiana Guerranti
Patrizia Bruzzi
Guido Perra
Silvano E. Focardi
author_facet Barbara Predieri
Lorenzo Iughetti
Cristiana Guerranti
Patrizia Bruzzi
Guido Perra
Silvano E. Focardi
author_sort Barbara Predieri
collection DOAJ
description Background. Impairments of endocrine system may be associated with exposure to perfluorinated compounds that are able to bind nuclear receptors, including the peroxisome proliferator-activating receptors. Aim of this study was to assess perfluorooctane sulfonate and perfluorooctanoic acid concentrations in children and adolescents at the onset of type 1 diabetes compared to healthy controls. Methods. Forty-four children and adolescents were recruited and subdivided into two groups: (A) 25 subjects with type 1 diabetes and (B) 19 healthy controls. Perfluorinated compounds were measured using high performance liquid chromatography with electrospray ionization tandem mass spectrometry. Nonparametric statistical analysis was performed. Results. Perfluorooctane sulfonate concentrations were significantly higher in patients with type 1 diabetes compared to controls (1.53 ± 1.50 versus 0.55 ± 0.15 ng/mL, resp.; p<0.001). Multivariate linear regression analysis identified lipid levels as significant predictive factors for perfluorooctane sulfonate levels. Conclusions. Our data suggests that higher serum levels of perfluorooctane sulfonate may be considered a biomarker of exposure and susceptibility to develop type 1 diabetes.
format Article
id doaj-art-6719257533f2456696c46dd74c7447aa
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-6719257533f2456696c46dd74c7447aa2025-02-03T01:02:56ZengWileyInternational Journal of Endocrinology1687-83371687-83452015-01-01201510.1155/2015/234358234358High Levels of Perfluorooctane Sulfonate in Children at the Onset of DiabetesBarbara Predieri0Lorenzo Iughetti1Cristiana Guerranti2Patrizia Bruzzi3Guido Perra4Silvano E. Focardi5Department of Medical and Surgical Sciences of the Mother, Children and Adults, University of Modena and Reggio Emilia, 41124 Modena, ItalyDepartment of Medical and Surgical Sciences of the Mother, Children and Adults, University of Modena and Reggio Emilia, 41124 Modena, ItalyDepartment of Environmental Sciences “G. Sarfatti”, University of Siena, 53100 Siena, ItalyDepartment of Medical and Surgical Sciences of the Mother, Children and Adults, University of Modena and Reggio Emilia, 41124 Modena, ItalyDepartment of Environmental Sciences “G. Sarfatti”, University of Siena, 53100 Siena, ItalyDepartment of Environmental Sciences “G. Sarfatti”, University of Siena, 53100 Siena, ItalyBackground. Impairments of endocrine system may be associated with exposure to perfluorinated compounds that are able to bind nuclear receptors, including the peroxisome proliferator-activating receptors. Aim of this study was to assess perfluorooctane sulfonate and perfluorooctanoic acid concentrations in children and adolescents at the onset of type 1 diabetes compared to healthy controls. Methods. Forty-four children and adolescents were recruited and subdivided into two groups: (A) 25 subjects with type 1 diabetes and (B) 19 healthy controls. Perfluorinated compounds were measured using high performance liquid chromatography with electrospray ionization tandem mass spectrometry. Nonparametric statistical analysis was performed. Results. Perfluorooctane sulfonate concentrations were significantly higher in patients with type 1 diabetes compared to controls (1.53 ± 1.50 versus 0.55 ± 0.15 ng/mL, resp.; p<0.001). Multivariate linear regression analysis identified lipid levels as significant predictive factors for perfluorooctane sulfonate levels. Conclusions. Our data suggests that higher serum levels of perfluorooctane sulfonate may be considered a biomarker of exposure and susceptibility to develop type 1 diabetes.http://dx.doi.org/10.1155/2015/234358
spellingShingle Barbara Predieri
Lorenzo Iughetti
Cristiana Guerranti
Patrizia Bruzzi
Guido Perra
Silvano E. Focardi
High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes
International Journal of Endocrinology
title High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes
title_full High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes
title_fullStr High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes
title_full_unstemmed High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes
title_short High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes
title_sort high levels of perfluorooctane sulfonate in children at the onset of diabetes
url http://dx.doi.org/10.1155/2015/234358
work_keys_str_mv AT barbarapredieri highlevelsofperfluorooctanesulfonateinchildrenattheonsetofdiabetes
AT lorenzoiughetti highlevelsofperfluorooctanesulfonateinchildrenattheonsetofdiabetes
AT cristianaguerranti highlevelsofperfluorooctanesulfonateinchildrenattheonsetofdiabetes
AT patriziabruzzi highlevelsofperfluorooctanesulfonateinchildrenattheonsetofdiabetes
AT guidoperra highlevelsofperfluorooctanesulfonateinchildrenattheonsetofdiabetes
AT silvanoefocardi highlevelsofperfluorooctanesulfonateinchildrenattheonsetofdiabetes